PROTECT-trial Consortium

The PROTECT-trial Consortium will conduct the phase three clinical trial:
PROtons vs Photon Therapy for Esophageal Cancer- a Trimodality strategy.

[PROTECT-trial Consortium @PROTECT_trial]

The first Italian PROTECT patient has been treated with protons at the Trento Proton Therapy Centre. Read more on why Trento participates in the PROTECT study, https://t.co/OC2AhSLkzA

[PROTECT-trial Consortium @PROTECT_trial]

Read the paper here: https://t.co/jZshnQ6vDE

[PROTECT-trial Consortium @PROTECT_trial]

The PROTECT RTQA paper has been published. View of Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

[PROTECT-trial Consortium @PROTECT_trial]

We're now on Bluesky! Follow us at @protect-trial.bsky.social for the latest updates on the PROTECT study.

[PROTECT-trial Consortium @PROTECT_trial]

The RTQA group visited USZ and PSI (Switzerland). Through the exchange of treatment experiences, these visits are of great value to the PROTECT study and the participating sites. All with the common goal of improving the treatment of esophageal cancer. (https://t.co/b7TozOGUaf)

[PROTECT-trial Consortium @PROTECT_trial]

To read more about the RTQA work in the PROTECT study: https://t.co/2e5vTfOqV3

[PROTECT-trial Consortium @PROTECT_trial]

First of the yearly RTQA meetings in the PROTECT trial. Great success with a lot of fantastic contributions and discussions. More than 40 participants. Thank you for joining. Looking forward to continued collaboration.

[PROTECT-trial Consortium @PROTECT_trial]

The PROTECT protocol paper is now online.
https://t.co/oKayUSC7K3

[PROTECT-trial Consortium @PROTECT_trial]

The Paul Scherrer Institute (@psich_de) and University Hospital Zurich(@Unispital_USZ) are now treating PROTECT patients in Switzerland. Read more at: https://t.co/K30iewpfoI. This marks the 25th patient in the PROTECT study.

[PROTECT-trial Consortium @PROTECT_trial]

First of many site visits completed. As a part of the PROTECT study all RT sites goes through an ambitions review program. AUH/DCPT had the pleasure of being quality assured by staff from @OncoRay_Press & @MAASTROclinic. Read more about WP3 QA at https://t.co/hrQbAJrcK0

[PROTECT-trial Consortium @PROTECT_trial]

Congratulations to @UZLeuven

[PROTECT-trial Consortium @PROTECT_trial]

PROTECT is now an active multicenter study, after the first patient has started treatment at the proton therapy center PARTICLE in UZ Leuven, BE. For more information visit:
https://t.co/3raE4ofofB

[PROTECT-trial Consortium @PROTECT_trial]

The first of 396 patients has been enrolled into the PROTECT study with the aim of setting new standards
for the clinical use of proton radiotherapy in esophageal cancer. For more information visit: https://t.co/je3ndVOIgq

[PROTECT-trial Consortium @PROTECT_trial]

First PROTECT-trial publication:
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight european centres.
https://t.co/tCr6yU227r

[Asociación Española de PROTonterapia (#AEPROT) @RRobaina75]

Presentation, by Lone Hoffmann in #ESTRO2021.
OC-0631 - Proton and photon treatment planning comparison for oesophageal cancer between six European centres.
#aeprot #protontherapy #particletherapy #protonterapia #oesophagealcancer @PROTECT_trial

[Ane Appelt @cancerphysicist]

Lone Hoffmann presents (some of) the extensive pre-trial RTQA work for @PROTECT_trial. Getting 8 international proton centres to produce comparable & robust PT (and XRT!) plans is not straightforward. And, perhaps counterintuitively, XRT plans are overall less robust #ESTRO2021

[PROTECT-trial Consortium @PROTECT_trial]

Hear Lone Hoffmann present the PROTECT study protocol at #ESTRO2021:
Proton and photon treatment planning comparison for oesophageal cancer between six European centres.
Monday 30th Aug. 16.45-16.55 (CET)
Presentation Number: OC-0631

[PROTECT-trial Consortium @PROTECT_trial]

Hear @VarianMedSys @ibaworldwide & @CaiGrau's take on the potentials of the PROTECT-trial partnership and the joint ambitions to develop the clinical use of #ProtonTherapy.

For more information visit https://t.co/4IVoJpyFGq

[PROTECT-trial Consortium @PROTECT_trial]

19 partners join forces in European public-private partnership backed by @IMI_JU, @VarianMedSys and @ibaworldwide to gather clinical evidence within #ProtonTherapy for #EsophagealCancer.
Full press release on PROTECT-trial launch at https://t.co/hNxqcG0Sfn
#RadioTherapy #RadOnc